These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


159 related items for PubMed ID: 18334867

  • 1. Cost-effectiveness of cognitive behaviour therapy in addition to mebeverine for irritable bowel syndrome.
    McCrone P, Knapp M, Kennedy T, Seed P, Jones R, Darnley S, Chalder T.
    Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):255-63. PubMed ID: 18334867
    [Abstract] [Full Text] [Related]

  • 2. Predictors of treatment outcome after cognitive behavior therapy and antispasmodic treatment for patients with irritable bowel syndrome in primary care.
    Reme SE, Kennedy T, Jones R, Darnley S, Chalder T.
    J Psychosom Res; 2010 Apr; 68(4):385-8. PubMed ID: 20307706
    [Abstract] [Full Text] [Related]

  • 3. Cognitive behaviour therapy in addition to antispasmodic treatment for irritable bowel syndrome in primary care: randomised controlled trial.
    Kennedy T, Jones R, Darnley S, Seed P, Wessely S, Chalder T.
    BMJ; 2005 Aug 20; 331(7514):435. PubMed ID: 16093252
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical effectiveness of individual cognitive behavioral therapy for depressed older people in primary care: a randomized controlled trial.
    Serfaty MA, Haworth D, Blanchard M, Buszewicz M, Murad S, King M.
    Arch Gen Psychiatry; 2009 Dec 20; 66(12):1332-40. PubMed ID: 19996038
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Management of irritable bowel syndrome in primary care: feasibility randomised controlled trial of mebeverine, methylcellulose, placebo and a patient self-management cognitive behavioural therapy website. (MIBS trial).
    Everitt HA, Moss-Morris RE, Sibelli A, Tapp L, Coleman NS, Yardley L, Smith PW, Little PS.
    BMC Gastroenterol; 2010 Nov 18; 10():136. PubMed ID: 21087463
    [Abstract] [Full Text] [Related]

  • 15. Internet-delivered exposure and mindfulness based therapy for irritable bowel syndrome--a randomized controlled trial.
    Ljótsson B, Falk L, Vesterlund AW, Hedman E, Lindfors P, Rück C, Hursti T, Andréewitch S, Jansson L, Lindefors N, Andersson G.
    Behav Res Ther; 2010 Jun 18; 48(6):531-9. PubMed ID: 20362976
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Long-term follow-up of internet-delivered exposure and mindfulness based treatment for irritable bowel syndrome.
    Ljótsson B, Hedman E, Lindfors P, Hursti T, Lindefors N, Andersson G, Rück C.
    Behav Res Ther; 2011 Jan 18; 49(1):58-61. PubMed ID: 21092934
    [Abstract] [Full Text] [Related]

  • 19. Gut-directed hypnotherapy for irritable bowel syndrome: piloting a primary care-based randomised controlled trial.
    Roberts L, Wilson S, Singh S, Roalfe A, Greenfield S.
    Br J Gen Pract; 2006 Feb 18; 56(523):115-21. PubMed ID: 16464325
    [Abstract] [Full Text] [Related]

  • 20. Cost-effectiveness modeling of intrathecal baclofen therapy versus other interventions for disabling spasticity.
    Bensmail D, Ward AB, Wissel J, Motta F, Saltuari L, Lissens J, Cros S, Beresniak A.
    Neurorehabil Neural Repair; 2009 Feb 18; 23(6):546-52. PubMed ID: 19228818
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.